Epidarex Capital is a private equity general partner firm with offices in Japan, South Korea and United States.
Enterprise Therapeutics, a UK-based drug discovery company, closed a £4m funding round led by Epidarex Capital and Imperial Innovations.
Mironid, a UK-based drug discovery company, closed its £4.3m Series A funding round led by Epidarex Capital.
Gimv joined Epidarex Capital and EMBL Ventures in a €14m Series A round for German biopharmaceutical company Topas Therapeutics.
Read more news concerning Epidarex Capital
A sampling of Epidarex Capital portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?